Pretomanid: A Breakthrough Antibiotic for Tuberculosis Treatment
Discover the power of Pretomanid in combating multi-drug resistant tuberculosis, offering new hope for patients worldwide.
Get a Quote & SampleProduct Core Value
Pretomanid
Pretomanid is a revolutionary nitroimidazole antibiotic designed to combat challenging strains of tuberculosis. Its unique mechanism of action makes it a vital component in the fight against multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
- Leveraging potent in vitro and in vivo activity against multi-drug resistant tuberculosis strains, Pretomanid offers a new avenue for treatment.
- As a key anti-tuberculosis drug, it shows significant efficacy against both replicating and non-replicating Mycobacterium tuberculosis.
- Developed by TB Alliance, Pretomanid is a testament to dedicated drug development, addressing a critical unmet medical need.
- Its synergistic effect when used with bedaquiline and linezolid makes it a cornerstone of modern TB treatment regimens.
Key Advantages Offered
Broad-Spectrum Efficacy
Effective against drug-resistant and latent TB strains, Pretomanid provides a broad therapeutic window for various forms of tuberculosis.
Innovative Mechanism
Its novel mechanism targeting cell wall synthesis and acting as a nitric oxide donor sets it apart from traditional antibiotics, overcoming existing resistance patterns.
Essential Medicine Status
Recognized globally, Pretomanid is included in essential medicine lists, highlighting its importance in public health and its role as a new TB drug candidate.
Key Applications
Tuberculosis Treatment
Pretomanid is primarily used for the treatment of pulmonary extensively drug resistant tuberculosis and nonresponsive MDR-TB.
Treatment of Latent TB
The drug shows promise against drug against latent tuberculosis, a challenging aspect of TB infection management.
Combination Therapy
It is an integral part of combination therapies, enhancing treatment outcomes for severe TB cases.
Research and Development
Continues to be a subject of research for potential new applications and improved TB regimens.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).